Advertisement
Device Sectors
Subscribe to Device Sectors
View Sample

FREE Email Newsletter

PET Scans with Florbetapir F 18 Help Alzheimer's Diagnosis

July 15, 2011 1:35 pm | by Diagnostic Imaging | News | Comments

Positron emission tomography (PET) combined with the tracer florbetapir F 18 showed significant differences in beta-amyloid burden in the brains of patients with probable Alzheimer's disease, mild cognitive impairment, and healthy older adults, according to a new study.

The Living Document: Digitizing Film-Based Radiographs

July 15, 2011 10:34 am | by Diagnostic Imaging | News | Comments

Many smaller radiology departments are still using film-based radiographs to present teaching files in a conference format. This presents a challenge to both the viewer and the presenter due to space limitations around the view box, degradation of film quality, and lack of consistency with format.

MRI Enterography Preferred for Children with IBD

July 15, 2011 10:34 am | by Diagnostic Imaging | News | Comments

Magnetic resonance enterography should be the imaging method of choice for radiologists diagnosing children with inflammatory bowel diseases, a new study published online in the American Journal of Roentgenology argues.

Advertisement

Shire plc : Second Quarter 2011 Results Date Notification - July 28, 2011

July 15, 2011 8:47 am | by Bio-Medicine.Org | News | Comments

DUBLIN, July 15, 2011 /-   Shire plc (LSE: SHP, NASDAQ: SHPGY ), the global specialty biopharmaceutical company, will announce second quarter 2011 earnings on Thursday July 28, 2011. Results press release will be issued at: 12:00 BST / 07:00 EDT Investor conference call time: 14:00...

UCLA Receives Six UC Health Quality Grants to Improve Hospital Care

July 15, 2011 8:47 am | by Bio-Medicine.Org | News | Comments

LOS ANGELES, July 15, 2011 /PRNewswire-USNewswire/ -- A key component of health care reform involves the improvement of quality, access and value when delivering health services, particularly for patients admitted to a hospital. To help meet these needs, the University of California...

Crestor and Zocor Drugs Linked to Muscle Degeneration, Rhabdomyolysis

July 15, 2011 8:42 am | by Bio-Medicine.Org | News | Comments

EDISON, N.J., July 15, 2011 /- Crestor and Zocor are widely-used prescription strength drugs designed to lower "bad cholesterol". Both drugs are classified as "statins", medicine which lowers blood cholesterol levels by inhibiting HMG-CoA reductase. This group of drugs has had a...

Town Hall Discussion With the Director of CDRH and Other Senior Center Management, September 22, 2011

July 15, 2011 6:30 am | by U.S. Food & Drug Administration | News | Comments

In 2010, CDRH held three Town Hall meetings in Minneapolis, Boston, and Los Angeles to provide the public with a new venue to discuss issues of interest with the Center. Due to positive feedback, we planed three more this year. In March 2011, the...

XGEVA® (Denosumab) Granted Marketing Authorization in the European Union

July 15, 2011 3:43 am | by Bio-Medicine.Org | News | Comments

THOUSAND OAKS, Calif., July 15, 2011 /- Amgen (NASDAQ: AMGN) today announced that the European Commission (EC) has granted marketing authorization for XGEVA® (denosumab) for the prevention of skeletal-related events (SREs) (pathological fracture, radiation to bone, spinal cord...

Advertisement

Coriell Institute Teams With IBM to Advance Personalized Medicine

July 15, 2011 3:40 am | by Bio-Medicine.Org | News | Comments

ARMONK, N.Y. and CAMDEN, N.J., July 15, 2011 /- IBM (NYSE: IBM ) today announced that Coriell Institute for Medical Research, the largest biobank of living human cells, is using IBM technology to advance its research of human genetic disease and to more efficiently maintain its massive...

Span-America Announces Third Quarter Conference Call on the Internet

July 14, 2011 11:38 am | by Bio-Medicine.Org | News | Comments

GREENVILLE, S.C., July 14, 2011 /- Span-America Medical Systems, Inc. (NASDAQ: SPAN ) will provide an online, real-time webcast and rebroadcast of its conference call on Friday, July 29, 2011, covering results for the third quarter of fiscal 2011, which will be released after the...

MSA Schedules Second Quarter Earnings Webcast

July 14, 2011 11:37 am | by Bio-Medicine.Org | News | Comments

PITTSBURGH, July 14, 2011 /- MSA (NYSE: MSA ), the global leader in the development, manufacture and supply of products that protect people's health and safety, announced today that it will broadcast a second quarter 2011 earnings conference call live via the Internet on Thursday, July...

To Find the Key to Healthy Life

July 14, 2011 11:35 am | by Bio-Medicine.Org | News | Comments

SHENZHEN, China, July 14, 2011 /PRNewswire-Asia/ -- Owing to high-pressure life, many people spend more time working and they choose fast food instead of traditional cooking, meanwhile, less and less time is being used to exercise, the aforementioned disadvantageous factors have affected...

QuantRx Biomedical Corporation Provides Corporate Update

July 14, 2011 11:35 am | by Bio-Medicine.Org | News | Comments

PORTLAND, Ore., July 14, 2011 /- QuantRx® Biomedical Corporation (OTCQB:QTXB), an emerging leader in the development and commercialization of innovative diagnostic products based on its patented technology platforms, is pleased to announce that following the successful resolution and...

Advertisement

Stem Cell Treatment May Restore Cognitive Function in Patients with Brain Cancer

July 14, 2011 8:37 am | by AACR | News | Comments

Tweet • Cranial radiotherapy is known to lead to cognitive dysfunction. • Stem cells conformed to ethical guidelines. PHILADELPHIA - Stem cell therapy may restore cognition in patients with brain cancer who experience functional learning and memory loss often associated with radiation...

Cancer Mortality Rates are Higher in Men than Women

July 14, 2011 8:34 am | by AACR | News | Comments

Tweet • Disparity driven by gender differences in cancer incidence. • Cancer survival largely similar between men and women. • Research needed to understand gender disparities in cancer incidence. PHILADELPHIA - Overall cancer mortality rates are higher for men than women in the United...

Hologic to Participate in Four Investor Conferences

July 14, 2011 7:34 am | by Bio-Medicine.Org | News | Comments

BEDFORD, Mass., July 14, 2011 /- Hologic, Inc. (NASDAQ: HOLX ) today announced that company management will participate in the following conferences: Deborah Gordon, Vice President, Investor Relations, will host investor meetings at the Lazard Capital Markets Corporate Access Day in...

B. Braun Renal Therapies Division Announces Availability of Advanced Apheresis Therapy System

July 14, 2011 7:34 am | by Bio-Medicine.Org | News | Comments

BETHLEHEM, Pa., July 14, 2011 /- The Renal Therapies Division of B. Braun Medical Inc. (B. Braun) announced today the availability of the Plasmat™ Futura System for H.E.L.P. ®   LDL Apheresis therapy. This addition to B. Braun's existing H.E.L.P. ® therapy provides a...

Rcadia's Fully Automatic Calcium Score Assessment from Coronary CTA Shows Potential to Eliminate Need for Separate Scan

July 14, 2011 7:33 am | by Bio-Medicine.Org | News | Comments

NEWTON, Mass., July 14, 2011 /- Rcadia Medical Imaging has achieved proof-of-concept with the first fully automated software that performs calcium scoring directly from a coronary CT angiography (cCTA) study. This technology, the first to show strong correlation with the standard,...

Double Eagle Holdings Enters Into Supply Agreement with Platform Delivery Technologies Inc.

July 14, 2011 6:35 am | by Bio-Medicine.Org | News | Comments

AVENTURA, Fla., July 14, 2011 /- Double Eagle Holdings, Ltd. (OTCQB: DEGH), the parent company of Fuse Science, Inc. ( www.fusescience.com ), announced today that it has entered into a research and development agreement with Platform Delivery Technologies Inc. (PDT Inc.), a...

Convergen LifeSciences Announces Patent Award

July 14, 2011 6:32 am | by Bio-Medicine.Org | News | Comments

AUSTIN, Texas, July 14, 2011 /- Convergen LifeSciences , Inc. announced today that another United States Patent 7,977,468 has been awarded by the U.S. Patent and Trademark Office jointly to The University of Texas System Board of Regents and The Secretary, U.S. Department of Health and...

QuantRx Biomedical Settles Suit: Launches New PAD-Based Genomic Diagnostic Products

July 14, 2011 6:32 am | by Bio-Medicine.Org | News | Comments

PORTLAND, Ore., July 14, 2011 /- QuantRx® Biomedical Corporation (OTCBB:QTXB), an emerging leader in the development and commercialization of innovative diagnostic products based on its patented technology platforms for the worldwide healthcare industry, today announced that it has...

Information on Urogynecologic Surgical Mesh Implants

July 14, 2011 6:31 am | by U.S. Food & Drug Administration | News | Comments

Surgical mesh is a medical device that is generally used to repair weakened or damaged tissue. It is made from porous absorbable or non-absorbable synthetic material or absorbable biologic material.

Two Patients Undergo Stem-Cell Blindness Treatment

July 14, 2011 5:34 am | by Massachusetts Institute of Technology | News | Comments

A small biotech firm is the second company to start human tests of embryonic stem-cell therapy.

Continuity as Debiopharm Groupâ„¢ Management Moves Forward

July 14, 2011 2:36 am | by Bio-Medicine.Org | News | Comments

LAUSANNE, Switzerland, July 14, 2011 /-   Debiopharm Group™ (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of innovative therapies, primarily in oncology, has appointed a number of management figures to key positions,...

Inovio Pharmaceuticals Demonstrates Positive Immune Responses in Phase I Clinical Trial of SynConâ„¢ H5N1 Influenza Vaccine and Launches Multi-Subtype Influenza Vaccine Phase I

July 14, 2011 2:36 am | by Bio-Medicine.Org | News | Comments

BLUE BELL, Pa., July 14, 2011 /- Inovio Pharmaceuticals, Inc. (NYSE Amex: INO ), a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that significant T cell and antibody responses were generated in its Phase I...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading